Caredx to host symposium covering innovation in multimodal surveillance including aicav for post-cardiac transplant care

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will host a symposium to describe the latest innovations in post-cardiac transplant care at the hfsa (heart failure society of america) annual scientific meeting 2022 taking place in washington, d.c., september 30 - october 3.
CDNA Ratings Summary
CDNA Quant Ranking